114 related articles for article (PubMed ID: 32640025)
1. How Viral Sequence Analysis May Guide Development of Respiratory Syncytial Virus Monoclonal Antibodies.
Langedijk AC; Bont LJ
Clin Infect Dis; 2021 Dec; 73(11):e4409-e4410. PubMed ID: 32640025
[No Abstract] [Full Text] [Related]
2. Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus.
Tian P; Wang Y; Liu H; Yang Y; Wu X; Wei H; Chen T
Front Cell Infect Microbiol; 2019; 9():275. PubMed ID: 31417879
[TBL] [Abstract][Full Text] [Related]
3. Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo.
Crowe JE; Gilmour PS; Murphy BR; Chanock RM; Duan L; Pomerantz RJ; Pilkington GR
J Infect Dis; 1998 Apr; 177(4):1073-6. PubMed ID: 9534985
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of monoclonal antibodies that detect conserved proteins from Respiratory Syncytial Virus, Metapneumovirus and Adenovirus in human samples.
González LA; Vázquez Y; Mora JE; Palavecino CE; Bertrand P; Ferrés M; Contreras AM; Beckhaus AA; Riedel CA; Bueno SM
J Virol Methods; 2018 Apr; 254():51-64. PubMed ID: 29410056
[TBL] [Abstract][Full Text] [Related]
5. Clinical Potential of Prefusion RSV F-specific Antibodies.
Rossey I; McLellan JS; Saelens X; Schepens B
Trends Microbiol; 2018 Mar; 26(3):209-219. PubMed ID: 29054341
[TBL] [Abstract][Full Text] [Related]
6. An investigation of the genetic basis of increased susceptibility to neutralization by anti-fusion glycoprotein antibody arising on passage of human respiratory syncytial virus in cell culture.
Hiriote W; Gias EL; Welsh SH; Toms GL
J Med Virol; 2015 Jan; 87(1):130-40. PubMed ID: 24861209
[TBL] [Abstract][Full Text] [Related]
7. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.
Johnson S; Oliver C; Prince GA; Hemming VG; Pfarr DS; Wang SC; Dormitzer M; O'Grady J; Koenig S; Tamura JK; Woods R; Bansal G; Couchenour D; Tsao E; Hall WC; Young JF
J Infect Dis; 1997 Nov; 176(5):1215-24. PubMed ID: 9359721
[TBL] [Abstract][Full Text] [Related]
8. Enhanced neutralization of human respiratory syncytial virus by mixtures of monoclonal antibodies to the attachment (G) glycoprotein.
Martínez I; Melero JA
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2215-20. PubMed ID: 9747731
[TBL] [Abstract][Full Text] [Related]
9. Potent Human Single-Domain Antibodies Specific for a Novel Prefusion Epitope of Respiratory Syncytial Virus F Glycoprotein.
Xun G; Song X; Hu J; Zhang H; Liu L; Zhang Z; Gong R
J Virol; 2021 Aug; 95(18):e0048521. PubMed ID: 34160257
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the binding of monoclonal and polyclonal antibodies to the glycoproteins of antigenic variants of human respiratory syncytial virus by surface plasmon resonance.
McGill A; Marsh R; Craft AW; Toms GL
J Immunol Methods; 2005 Feb; 297(1-2):143-52. PubMed ID: 15777938
[TBL] [Abstract][Full Text] [Related]
11. Antigenic structure of human respiratory syncytial virus fusion glycoprotein.
López JA; Bustos R; Orvell C; Berois M; Arbiza J; García-Barreno B; Melero JA
J Virol; 1998 Aug; 72(8):6922-8. PubMed ID: 9658147
[TBL] [Abstract][Full Text] [Related]
12. Linear antigenic and immunogenic regions of the respiratory syncytial virus P protein.
Leonov SV; Utter G; Waris M; Norrby E
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1353-9. PubMed ID: 8207401
[TBL] [Abstract][Full Text] [Related]
13. Increased susceptibility of human respiratory syncytial virus to neutralization by anti-fusion protein antibodies on adaptation to replication in cell culture.
Marsh R; Connor A; Gias E; Toms GL
J Med Virol; 2007 Jun; 79(6):829-37. PubMed ID: 17457900
[TBL] [Abstract][Full Text] [Related]
14. Polyclonal and monoclonal antibodies specific for the six-helix bundle of the human respiratory syncytial virus fusion glycoprotein as probes of the protein post-fusion conformation.
Palomo C; Mas V; Vázquez M; Cano O; Luque D; Terrón MC; Calder LJ; Melero JA
Virology; 2014 Jul; 460-461():119-27. PubMed ID: 25010277
[TBL] [Abstract][Full Text] [Related]
15. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
[TBL] [Abstract][Full Text] [Related]
16. Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis.
Maas BM; Lommerse J; Plock N; Railkar RA; Cheung SYA; Caro L; Chen J; Liu W; Zhang Y; Huang Q; Gao W; Qin L; Meng J; Witjes H; Schindler E; Guiastrennec B; Bellanti F; Spellman DS; Roadcap B; Kalinova M; Fok-Seang J; Catchpole AP; Espeseth AS; Stoch SA; Lai E; Vora KA; Aliprantis AO; Sachs JR
EBioMedicine; 2021 Nov; 73():103651. PubMed ID: 34775220
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine.
Djagbare MD; Yu L; Parupudi A; Sun J; Coughlin ML; Rush BS; Sanyal G
Vaccine; 2018 Mar; 36(12):1673-1680. PubMed ID: 29456016
[TBL] [Abstract][Full Text] [Related]
18. Generation and epitope mapping of a sub-group cross-reactive anti-respiratory syncytial virus G glycoprotein monoclonal antibody which is protective in vivo.
Robinson MJ; Tan CS; Fenwick F; Chambers CJ; Routledge EG; Toms GL
J Med Virol; 2014 Jul; 86(7):1267-77. PubMed ID: 24415460
[TBL] [Abstract][Full Text] [Related]
19. Protection of mice against Human respiratory syncytial virus by wild-type and aglycosyl mouse-human chimaeric IgG antibodies to subgroup-conserved epitopes on the G glycoprotein.
Mekseepralard C; Toms GL; Routledge EG
J Gen Virol; 2006 May; 87(Pt 5):1267-1273. PubMed ID: 16603529
[TBL] [Abstract][Full Text] [Related]
20. Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes.
Fedechkin SO; George NL; Nuñez Castrejon AM; Dillen JR; Kauvar LM; DuBois RM
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
